Measurement · not graded
VO2max Testing
What the evidence looks at: agreement with cardiopulmonary exercise testing as the reference method, including verification-phase confirmation.
How this letter has changedLatest: September 2026 · First graded.
Same gap again. The record carries no letter: a test measures aerobic capacity and does not raise it, and the training that raises it is graded on its own records. It cites the methods literature on what makes a test maximal, and the validation work on the estimates consumer wearables report. Cited: Midgley et al. (Sports Med, 2007; PMID PubMed ID: the permanent number the US National Library of Medicine gives a published paper. Each one links to that paper's record on PubMed. 18027991); Schaun (Sports Med Open, 2017; PMID 29218470); Carrier et al. (Sensors (Basel), 2025; PMID 39797066).PMID 18027991 PMID 29218470 PMID 39797066
Every change to a letter on this site is dated and published. The full evidence log →
Diagnostic testing · Cardiovascular fitness
Cardiorespiratory fitness measured by VO2max is the single strongest independent predictor of all-cause mortality in the human evidence base. Being in the top quartile of VO2max for your age and sex is associated with a five-fold reduction in cardiovascular mortality compared to the bottom quartile. No supplement on this platform comes close to that effect size How large a difference the treatment made, as distinct from whether the difference could be detected at all.. This is the most important number you are probably not tracking.
| What it measures | Maximum oxygen consumption during maximal exertion. Unit: mL O2/kg/min. The gold standard is CPET (cardiopulmonary exercise testing) with metabolic cart. Estimated VO2max from submaximal tests (Fitbit, Apple Watch, Garmin) is useful for trending but less precise. |
| Gold standard | CPET at a sports medicine clinic, cardiology lab, or university exercise physiology lab. Requires medical clearance for high-risk individuals. |
| Consumer estimate | Wearable devices (Garmin, Polar, Apple Watch) provide estimated VO2max from heart rate during exercise. Useful for tracking trends. Not equivalent to CPET. |
| Cost | CPET: $150 to $400 out of pocket. Rarely covered by insurance for healthy adults. Wearable estimate: free with compatible device. |
| Frequency | CPET baseline, then every 1 to 2 years. Wearable estimate: continuous tracking. |
| Target | Top quartile for age and sex. General reference: above 45 mL/kg/min for men, above 35 mL/kg/min for women under 50. Declines roughly 1% per year without training from age 30. |
CPET result in mL/kg/min, percentile for age and sex. Wearable estimated VO2max trend over months. Resting heart rate trend (inverse proxy). Six-minute walk test distance (functional proxy for older adults). Annual retest recommended.
Retrospective cohort of 122,007 patients undergoing exercise treadmill testing. Elite fitness (top 2.5%) was associated with an 80 percent lower risk of all-cause mortality vs. low fitness. The mortality risk reduction from top to bottom fitness quintile was larger than the reduction from any traditional cardiovascular risk factor including smoking, hypertension, and diabetes.
Prospective cohort demonstrating a dose-response relationship between cardiorespiratory fitness and mortality across 750,302 veterans. No upper threshold was identified: higher VO2max continued to associate with lower mortality throughout the observed range.
Low cardiorespiratory fitness was identified as the strongest modifiable risk factor for cardiovascular disease and all-cause mortality, stronger than smoking, hypertension, obesity, and dyslipidemia. Called for VO2max to be adopted as a clinical vital sign.
CPET is safe for most healthy adults but requires medical clearance for people with known or suspected cardiovascular disease, recent cardiac events, uncontrolled hypertension, or significant arrhythmia. Testing facilities screen medications and medical history before a maximal exercise test.
Beta-blockers blunt the heart rate response and artificially lower VO2max estimates from wearables. CPET protocols can be adjusted for beta-blockade, which is why testing facilities ask about it. Some antihypertensives affect exercise blood pressure response.
EBL ranks VO2max improvement above every supplement in the database for all-cause mortality reduction. Zone 2 aerobic training is the primary evidence-based intervention. High-intensity interval training (HIIT) and REHIT (reduced exertion HIIT) are the most time-efficient approaches for raising VO2max in adults. See the structured exercise intervention page for protocol details.
Educational use only · Not medical advice · Starting, stopping or changing any supplement or medication is a decision for your physician
EBL does not verify the regulatory status of any device. Many consumer wellness devices are not FDA-cleared The FDA found a device substantially equivalent to one already on the market. Clearance is not approval and does not require trials showing benefit., and FDA clearance, where it exists, applies only to specific indications. The grade on this page describes the strength of published human trial evidence in the populations studied. It is not a recommendation for any individual and is not medical advice. Using any device for a health purpose is a decision for your physician.
Primary evidenceThree papers, each linked to its PubMed record.
Howley-era criteria for calling a test maximal are contested: Midgley and colleagues (Sports Medicine, 2007; PMID 18027991) criticize the plateau and secondary criteria in common use, and Schaun (Sports Medicine Open, 2017; PMID 29218470) reviews the verification phase as the confirmation step. Validation of aerobic capacity and pulse oximetry in wearable technology (Sensors, 2025; PMID 39797066) covers the estimates consumer devices report. All three are methods papers, not outcome trials.
These statements have not been evaluated by the Food and Drug Administration. Any grade on this page describes the strength of published human trial evidence in the populations studied. It is not a recommendation for any individual and is not medical advice. Starting, stopping or changing any supplement or medication is a decision for your physician.
Papers authored on this record that are not linked elsewhere on the page. Every citation the record carries is reachable from the page it grades.
Grades move when new trials publish. A free monthly email lists every grade EBL moved, with the reason and the trial behind it: the sign-up is on the Evidence Log →